Table 1.
Studies in the literature on RPM in PD
| Study, reference | Design | Participants | Follow-up time | Outcome | Result |
|---|---|---|---|---|---|
| Corzo et al. [11] |
Retrospective Multicentre Observational |
148 patients with RPM and 410 patients without RPM | 1.1 ± 0.6 years | Technique survival | RPM associated with higher technique survival |
| Bunch et al. [12] | Observational | 1023 patients with RPM and effect of COVID-19 | 4 months |
Adherence Peritonitis Blood pressure |
During the COVID-19 pandemic, increased patients’ adherence and blood pressure control similar peritonitis rate |
| Walker et al. [13] | Qualitative, interview | 27 patients with RPM and 7 caregivers | – | Expectation experience | Increased patient knowledge on the disease; enhanced partnership with clinician |
| Walker et al. [14] | Qualitative, interview | 13 nurses, 12 nephrologists | – |
Perspective experience |
Enhanced patients focused care; emphasized patient privacy and boundaries |
| Manani et al. [15] | Retrospective | 35 patients with RPM and 38 patients without RPM | 6 months |
HRQoL Hospitalization Urgent visit Peritonitis |
Decreased in disease-specific hospitalization and length of stay and urgent visit; similar peritonitis and HRQoL |
|
Yeter et al. [7] |
Observational | 15 patients pre- and post-RPM | 6 months |
Adherence Blood pressure Adequacy Drug burden HRQoL Sleep quality |
Increased adherence and dialysis adequacy; better blood pressure control; decreased drug burden; similar sleep quality and HRQoL |
|
Yeter et al. [16] |
Observational cross-sectional | 15 CAPD, 20 RPM–APD and 38 healthy control | 12 months |
Hypervolaemia, Central haemodynamics and peripheral blood pressure Drug burden |
RPM was associated with better control of haemodynamic parameters with less antihypertensive drugs via controlling the excess body water |
| Ariza et al. [17] | Amorkov projection model | 100 APD patients | – |
Health cost Hospitalization Peritonitis |
Decreased $121 233 in annual health cost; 27 fewer hospitalizations; 518 fewer hospitalization days and 6 fewer peritonitis episodes |
|
Yeter et al. [18] |
Observational cross-sectional | 53 CAPD, 40 RPM–APD and 30 APD and effect of COVID-19 | 97 ± 31 days |
Laboratory parameters Blood pressure Depression |
RPM–APD provided better laboratory parameters; similar blood pressure control; depression may affect the accuracy of clinical assessment. |
| Sanabria et al. [6] | Retrospective | 63 patients with and without RPM; 1:1 propensity score matching | 12 months | Hospitalization | 0.36 fewer hospitalizations per patient-year and 6.57 fewer days per patient-year with RPM |
| Manani et al. [1] | Observational | 43 patients with RPM and 42 patients without RPM | 12 months |
Health cost Hospital visit QoL |
RPM–APD was cost-effective; decreased hospital visit; increased QoL according to the internal questionnaire |
|
Bunch et al. [10] |
Observational | 49 patients pre- and post-RPM | 2 months |
Adherence Peritonitis Blood pressure |
85% treatment adherence; similar peritonitis and technique failure; decreased diastolic blood pressure |
|
Uchiyama et al. [19] |
Simulation | 12 patients | – |
Health cost Hospital visit Hospitalization |
Decreased health cost and hospital visit; similar hospitalization |
| Manani et al. [20] | Observational | 37 patients pre- and post-RPM | 12 months |
Hospital visit Treatment adequacy |
Decreased hospital visit, similar treatment adequacy |
| Makhija et al. [2] | Simulation | 12 patients | – | Health cost | Decreased health cost |
|
Sanabria et al. [9] |
Cross-sectional | 396 patients with RPM | – |
Adherence Blood pressure |
90.1% adherence; 55.5% blood pressure <140/90 mmHg |
RPM–APD, RPM with APD; QoL, quality of life.